Abstract

During cancer treatment, doses must be carefully administered and monitored to guarantee efficacy and minimize side-effects. A potentiometric sensor was developed for the direct real-time assay of a widely used antineoplastic drug (vinblastine (VB)) in plasma samples. Membrane cocktails were drop-casted over a glassy-carbon electrode coated with a lipophilic conducting polymer (polyaniline). The study investigated five cation exchangers, five plasticizers (of different polarities and dielectric constants), and four ionophores with different physicochemical characters on the sensor performance. The study substantiates a data-driven selection of the optimum membrane recipe. The latter included sodium tetraphenylborate as an ion exchanger, dioctylphthalate as a plasticizer, and hydroxypropyl-β-cyclodextrin as ionophore. The membrane proved a near-Nernstian slope of 37.5 mV per decade, a LOQ of 2.99 × 10−6 M, and a stable fast response. The selectivity study proved poor responses to common physiological ions. The developed sensor was used for the determination of VB in its pure powder form, marketed formulation, and plasma samples. The fast and direct sensor response enables a wide range of applications in quality control laboratories and clinical studies.

Highlights

  • Cancer is the uncontrollable growth and spread of abnormal cells throughout the body organs

  • Different membrane cocktails were prepared in 5 mL volumetric asks by transferring accurately weighed amounts of the membrane components including PVC, ion-exchanger (PM, phosphotungstic acid (PT), TPB, RK, and TKS), plasticizer (NPOE, dioctyl phthalate (DOP), dibutyl phthalate (DBP), dibutyl sebacate (DBS), and nitrophenyl phenyl ether (NPPE)), and ionophore (HPBCD, BCD, CMBCD, and CX8)

  • The results indicated that DOP modi es the membrane characteristics to enable faster exchange kinetics with vinblastine sulfate (VB) ions

Read more

Summary

Introduction

Cancer is the uncontrollable growth and spread of abnormal cells throughout the body organs. WHO ranks cancer as the second leading cause of death worldwide. Cancer claimed 9.6 million lives (one-sixth of the deaths) in 2018. The uneven distribution of mortalities reinforces the conclusion that early diagnosis and quality treatment contribute to signi cantly higher survival rates in developed countries than developing countries.[1]. Vinblastine is a well-tolerated inexpensive chemotherapeutic alkaloid extracted from Madagascar periwinkle known as Catharanthus roseus or Vinca rosea. The plant produces a similar chemotherapeutic alkaloid called vincristine that slightly differs in chemical structure,[2] (ESI Fig. S1†). Vinblastine is less expensive, and 1000 times more abundant in Vinca rosea than vincristine.[3]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call